Drug Shortage Report for ABILIFY MAINTENA
| Report ID | 145172 |
| Drug Identification Number | 02420864 |
| Brand name | ABILIFY MAINTENA |
| Common or Proper name | Abilify Maintena |
| Company Name | OTSUKA PHARMACEUTICAL CO LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ARIPIPRAZOLE |
| Strength(s) | 300MG |
| Dosage form(s) | KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | kit |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-09-15 |
| Actual start date | 2021-09-15 |
| Estimated end date | |
| Actual end date | 2021-09-27 |
| Shortage status | Resolved |
| Updated date | 2021-09-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-09-28 | French | Compare |
| v6 | 2021-09-28 | English | Compare |
| v5 | 2021-09-16 | English | Compare |
| v4 | 2021-09-09 | French | Compare |
| v3 | 2021-09-09 | English | Compare |
| v2 | 2021-09-03 | French | Compare |
| v1 | 2021-09-03 | English | Compare |
Showing 1 to 7 of 7